PP_1170x120_10-25-21

Professional golfer James Hahn

Professional golfer James Hahn partners with IBSA Pharma to promote Licart

Professional golfer James Hahn partners with IBSA Pharma to promote Licart

PARSIPPANY, N.J. — Professional golfer James Hahn has partnered with IBSA Pharma Inc. to promote Licart, the pharmaceutical company’s newest topical pain product. Licart (diclofenac epolamine) topical system 1.3% is the first and only once-a-day topical nonsteroidal anti-inflammatory drug (NSAID) approved by the Food and Drug Administration (FDA) to treat acute pain due to minor strains, sprains, and contusions. As part

Adheris Health